Skip to content

F&P Optiflow TRACE

by Fisher & Paykel Healthcare Limited 3 variants

Ref AA031L

F&P Optiflow TRACE (AA031L) is a Class IIa device made by Fisher & Paykel Healthcare Limited, registered in EUDAMED on 3 Sep 2026 (Basic UDI-DI B-09420012453303), active as of 8 Nov 2026.

Active European Union

CE MDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-09420012453303 Basic UDI-DI 09420012453303UDI-DIDate3 Sep 2026RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDD Active

Specification

EUDAMED

Device name
Optiflow Filtered Nasal Interface with CO2 Sampling
Model / reference
AA031L
Primary DI / UDI-DI
09420012453303
Basic UDI-DI
B-09420012453303
EMDN code
R0301020302 High flow therapy nasal cannulas (hfnc)
Device class
Class IIa
EU registration type
Legacy device (under a directive)
EU market of registration
France

Manufacturer details

EUDAMED SRN
NZ-MF-000002556
Authorised representative
FISHER & PAYKEL HEALTHCARE SAS FR-AR-000000294

Similar devices in this category

Other devices filed under HIGH FLOW THERAPY NASAL CANNULAS (HFNC).

Other devices from Fisher & Paykel Healthcare Limited

See all devices from Fisher & Paykel Healthcare Limited →

Properties

Other properties (12, all answered No)